Clinical Trial Update: Dopamine and Norepinephrine in Shock Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating dopamine and norepinephrine in patients with shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Shock

Drugs mentioned

• Dopamine (dopamine)
• NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)

Snippet

Sponsor: Sepsis Occurrence in Acutely Ill Patients | Conditions: Shock | Phase 3 | Status: COMPLETED